Physician profile
Anna Kim
NPI 1063869352
$1,359.18
in general payments reported to CMS, 2019-2025
15 companies · $259 in 2025
The $259 reported for 2025 was less than what a typical Mohs-Micrographic Surgery provider received nationally (typical 2025 total: $462).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $114 · 2022: $140 · 2023: $218 · 2024: $628 · 2025: $259.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,105.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,105.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $521.84 | 2019-2025 | |
| Genzyme Corporation | $261.40 | 2023-2025 | |
| Leo Pharma INC. | $174.94 | 2023-2025 | Adbry |
| Janssen Biotech, INC. | $82.19 | 2022-2023 | Simponi, Simponi Aria, Remicade |
| Incyte Corporation | $71.51 | 2022-2025 | Opzelura |
| Ucb, INC. | $65.84 | 2023-2024 | Bimzelx |
| Novartis Pharmaceuticals Corporation | $28.35 | 2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $28.17 | 2023 | Spevigo |
| Organon LLC | $27.37 | 2024 | |
| Lilly USA, LLC | $19.16 | 2024 | Olumiant, Taltz |
| Mimedx Group, INC. | $17.64 | 2024 | |
| Sun Pharmaceutical Industries INC. | $16.60 | 2023 | Blu-U, Odomzo |
| Botanix Sb INC | $15.63 | 2025 | Sofdra |
| Galderma Laboratories, L.P. | $15.08 | 2024 | |
| Almirall LLC | $13.46 | 2024 | Klisyri |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anna Kim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.